Feifei Cui

发表

Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.

Fudong Yu, Su Lu, Hua-mei Tang, 2014, Biochemical and biophysical research communications.

Decreased MALL expression negatively impacts colorectal cancer patient survival

Bin Wang, Zongguang Zhou, Fudong Yu, 2016, Oncotarget.

Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer

Su Lu, Senlin Zhao, Hua-mei Tang, 2015, Journal of experimental & clinical cancer research : CR.

Period 1 and estrogen receptor-beta are downregulated in Chinese colon cancers.

Fudong Yu, Hua-mei Tang, Zhihai Peng, 2015, International journal of clinical and experimental pathology.

Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma.

Fudong Yu, Zhihai Peng, Meng Zhang, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer

Hua-mei Tang, Zhihai Peng, Xiao Wang, 2015, Journal of Experimental & Clinical Cancer Research.

Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.

Su Lu, Hua-mei Tang, Zhihai Peng, 2014, International journal of clinical and experimental pathology.

TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway.

B. Zheng, Jingwu Z. Zhang, Feifei Cui, 2013, Journal of molecular cell biology.

Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer

Su Lu, Senlin Zhao, Hua-mei Tang, 2015, Journal of experimental & clinical cancer research : CR.

Zinc-α-2-Glycoprotein: A Candidate Biomarker for Colon Cancer Diagnosis in Chinese Population

Fudong Yu, Senlin Zhao, Hua-mei Tang, 2014, International journal of molecular sciences.

PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy

Fudong Yu, Senlin Zhao, Hua-mei Tang, 2014, Oncotarget.

DDA1 promotes stage IIB–IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling

Zongguang Zhou, Fudong Yu, Xisheng Liu, 2016, Oncotarget.

Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer

Hua-mei Tang, Zhihai Peng, Xiao Wang, 2015, Journal of experimental & clinical cancer research : CR.

Ubiquitin D is an independent prognostic marker for survival in stage IIB–IIC colon cancer patients treated with 5‐fluoruracil‐based adjuvant chemotherapy

Senlin Zhao, Hua-mei Tang, Zhihai Peng, 2015, Journal of gastroenterology and hepatology.

PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy

Fudong Yu, Senlin Zhao, Hua-mei Tang, 2014, OncoTarget.